Multiple Basal Cell Carcinomas in Immunocompetent Patients
- PMID: 35804983
- PMCID: PMC9264959
- DOI: 10.3390/cancers14133211
Multiple Basal Cell Carcinomas in Immunocompetent Patients
Abstract
Background: The onset of multiple BCCs is a relatively common condition, not only among patients undergoing chronic treatment with immunosuppressant drugs, but also in the general population, although specific risk factors for immunocompetent patients have not been identified. A putative role of somatic mutations in the hedgehog pathway should be considered.
Methods: This study is a retrospective observation of all patients diagnosed and surgically treated for BCCs during 5 years at our Dermatological Division. For these patients, we evaluated clinical and histopathological characteristics and data about possible risk factors for BCC.
Results: Five-hundred and six patients affected by multiple BCCs, accounting for the 24.2% of the entire sample, have been identified. In these patients, the total number of BCCs was 1516, ranging from 2 to 11. Subjects affected by multiple BCCs were more frequently males, with an older age at diagnosis; multiple BCCs developed mainly on the trunk and were often represented by a nodular histotype. The multivariate analysis highlighted that male gender, older age, nodular BCC, or face involvement at the first diagnosis are risk factors for the development of multiple BCCs.
Conclusions: The frequency of multiple BCCs even among the non-immunocompromised population underlines the need to subject patients to a close surveillance program, to allow early diagnosis and treatment of additional cancers.
Keywords: UV-exposure; basal cell carcinoma; hedgehog pathway; mutational status; non-melanoma skin cancer; risk factors.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Leiter U., Eigentler T., Garbe C. Epidemiology of skin cancer. Adv. Exp. Med. Biol. 2014;810:120–140. - PubMed
-
- Niwa A.B.M., Pimentel E.R.A. Carcinoma basocelular em localizações incomuns. An. Bras. Dermatol. 2006;81:S281–S284. doi: 10.1590/S0365-05962006000900005. - DOI
-
- Wisgerhof H.C., Edelbroek J.R., de Fijter J.W., Haasnoot G.W., Claas F.H., Willemze R., Bavinck J.N. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer, Cumulative incidence and risk factors. Transplantation. 2010;89:1231–1238. doi: 10.1097/TP.0b013e3181d84cdc. - DOI - PubMed
LinkOut - more resources
Full Text Sources